Biogen (BIIB) Cash from Operations (2009 - 2026)

Biogen's Cash from Operations history runs 18 years deep, the most recent figure standing at 645500000.0 for Q1 2026.

• In Q1 2026, Cash from Operations rose 148.94% year-over-year to 645500000.0; the TTM figure through Mar 2026 stood at 2590800000.0 (changed 0.36% YoY), while the FY2025 annual figure was 2204600000.0, down 23.33% from the prior year.
• Cash from Operations was 645500000.0 for Q1 2026 at Biogen, up from 511900000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 1272500000.0 in Q3 2025 to a low of 175000000.0 in Q4 2022.
• Historically, Cash from Operations has averaged 509241176.47 across 5 years, with a median of 553200000.0 in 2024.
• The sharpest annual moves came in 2022 and 2024: Cash from Operations slumped 120.88% in 2022, then soared 5987.2% in 2024.
• A 5-year view of Cash from Operations shows it stood at 175000000.0 in 2022, then surged by 107.14% to 12500000.0 in 2023, then jumped by 5987.2% to 760900000.0 in 2024, then slumped by 32.72% to 511900000.0 in 2025, then increased by 26.1% to 645500000.0 in 2026.
• The last three Cash from Operations figures came in at 645500000.0 (Q1 2026), 511900000.0 (Q4 2025), and 1272500000.0 (Q3 2025), per Business Quant data.